Oligonucleotide synthesis and purification facility

Publié le

Marcel Hollenstein, Institut Pasteur, head of laboratory of Bioorganic Chemistry of Nucleic Acids nous parle de ce plateau.

Our small oligonucleotide synthesis and purification facility aims at producing chemically modified sequences ranging from 2 to ~100 nucleotides. These modified oligonucleotides are key elements in our PEPR project since modulation of the pH will particularly affect the modified nucleotides.

Consequently, a modification of the pH will directly change the nature of the nucleotide that will be incorporated by polymerases via templating modifications. Such modified sequences will also be used in ligase-based approaches to construct yet longer (i.e. up to 1000 nt) modified sequences, the main aim of our project.

In addition, our facility can prepare oligonucleotides with alternative modification patterns of interest to any of the members of our consortium. This encompasses 5’/3’-terminal modifications such as biotin or thiol to immobilize sequences on surfaces such as electrodes or magnetic particles, abasic sites or universal bases to block polymerases or favor the introduction of any type of nucleotide, respectively, or other functional tags.

Following the design of sequences, directly in our lab or by our collaborators, we then synthesize the modified amidites if they are not commercially not available.

This is a multi-step synthesis project including thorough purification and analysis of the chemical integrity of all intermediates and final products. With all amidites in hand, we then initiate the synthesis of the sequences using our K&A DNA synthesizer.

After completion of the synthesis, the solid-support is treated with ammonia to remove the protecting groups and cleave the sequence off the resin. After removal of ammonia, the sequences are purified by RP-HPLC and/or anion exchange HPLC.

Finally, modified oligonucleotides are then subjected to an LC-MS and/or MALDI-ToF analysis prior to quantification. Sequences can then be sent to collaborators or used in house for downstream applications.

Historical perspective :

Initially, sequences were synthesized by a PhD student and a CNRS permanent researcher on a case-to-case situation. After hiring a research engineer in late 2024 in the framework of this PEPR project, the facility strongly improved its capacity. We are currently on the verge of acquiring a new DNA synthesizer to yet further increase our production capacity.

Duration for the synthesis of modified oligonucleotides

The exact duration of the synthesis of a modified sequence depends on a number of parameters including length of the sequence, number of modified nucleotides to be incorporated, and whether the modifications are commercially available or whether they need to be produced. In the worst case scenario, i.e. a long sequence (~92 nt) with multiple modifications which are not commercially available, at least two months should be considered from start to end. In the best case scenario, i.e. standard modifications on a short sequence (~15 nt which we prepare for another part of our PEPR project), the duration does not exceed 10 days.

As mentioned previously, the modified oligonucleotides are at the heart of the PEPR project because they represent the templates that will dictate the nature of the oligonucleotides produced by polymerases as a function of pH changes.

In addition to these longer templates, we have initiated a vast analysis of the effect of base-modifications on duplex stability as a function of pH and mispairing.

We believe that the results stemming from this vast analysis will facilitate the identification of alternative base-modifications to be used in longer templates. Potentially, the vast amount of data could be implemented in algorithms to predict the effect of pH on modifications on mispairing capacity.

Since the hiring of the research engineer, the facility has stepped into a new degree of maturity. We have also been able to produce some modified oligonucleotides that were only loosely connected to the PEPR project (e.g. for the chemoenzymatic labelling of oligonucleotides with GalNAc ligands in collaboration with the team of Yannick Rondelez) and external collaborators.

We will continue producing oligonucleotides for the PEPR project and are considering to implement backbone and sugar modifications to evaluate their dependence on alterations of pH. The future of the facility obviously strongly depends on the presence of our highly qualified research engineer.